恩替卡韦博路定~?和润众~?的国内专利布局策略对比分析

Comparative analysis of patent layout strategy of entecavir tablets and entecavir dispersible tablets in China

文章拟以恩替卡韦在国内申请的总体概况为研究对象,以正大天晴和百时美施贵宝的专利布局策略为例,通过分析恩替卡韦的国内专利申请情况,以期为医药创新者的创新研发及医药创新成果的保护提供借鉴和参考。

This paper intends to take the profile of entecavir application in China as the research object, and to analyzethe domestic patent application status of Entecavir, specifically combining with the patent layout strategy of CHIATAITIANQING and Bristol-Myers Squibb. And it is aimed at the purpose of providing reference for pharmaceutical innovative researches and protection of innovative achievements.